Lansforsakringar Fondforvaltning’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$417M Buy
348,001
+32,244
+10% +$32.9M 1.87% 9
2026
Q1
$290M Buy
315,757
+1,981
+0.6% +$2.01M 1.52% 11
2025
Q4
$337M Buy
313,776
+2,815
+0.9% +$2.69M 1.67% 10
2025
Q3
$237M Sell
310,961
-494
-0.2% -$368K 1.23% 12
2025
Q2
$243M Sell
311,455
-34,969
-10% -$27.2M 1.39% 12
2025
Q1
$286M Sell
346,424
-4,148
-1% -$3.45M 1.76% 7
2024
Q4
$271M Buy
+350,572
New +$290M 1.51% 10

Other funds holding LLY

Lansforsakringar Fondforvaltning's LLY Position: Q2 2026 in Review

Lansforsakringar Fondforvaltning increased its Eli Lilly (LLY) stake by 10% in Q2 2026, buying an estimated $32.9M and bringing the position to 348,001 shares worth $417M. The position accounts for 1.87% of the portfolio, ranked #9.

Lansforsakringar Fondforvaltning first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Lansforsakringar Fondforvaltning held 348,001 shares of Eli Lilly worth $417M as of Q2 2026.
  • Lansforsakringar Fondforvaltning bought 32,244 Eli Lilly shares in Q2 2026, an estimated $32.9M.
  • Eli Lilly made up 1.87% of Lansforsakringar Fondforvaltning's portfolio in Q2 2026, its #9 holding.
  • Lansforsakringar Fondforvaltning first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q2 2026, filed 13 Aug 2026.